A 58-year-old patient with type 2 diabetes presents with an HbA1c of 9.2%. Which medication class has the strongest evidence for reducing cardiovascular mortality in this population?
-
A
Sulfonylureas
-
B
SGLT-2 inhibitors
-
C
Alpha-glucosidase inhibitors
-
D
Thiazolidinediones